Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This coverage gap has created significant out-of-pocket costs for patients seeking these medications for obesity treatment
In preclinical and clinical studies, it has shown superior in vitro activity and consistent therapeutic effects in animal models
Li YF, Tseng PJ, Lin CC, Hung CL, Lin SC, Su WC, et al
pAkt, phosphorylated Akt
A systematic review ScienceDirect science/article/pii/S2214623724000048 [62] Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data ScienceDirect science/article/abs/pii/S0168822723001006 [63] GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)
US$ 23.00
US$ 23.82
US$ 23.75
US$ 23.44
US$ 22.89
